Suppr超能文献

了解系统性红斑狼疮患者的预期结果及其对使用皮质类固醇的风险和益处的看法。

Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.

机构信息

1 Department of Pharmaceutical Health Services Research, 12265 University of Maryland School of Pharmacy, Baltimore, MD, USA.

2 Department of Epidemiology and Public Health, 12265 University of Maryland School of Medicine, Baltimore, MD, USA.

出版信息

Lupus. 2018 Mar;27(3):475-483. doi: 10.1177/0961203317726375. Epub 2017 Aug 31.

Abstract

Introduction The use of corticosteroids in systemic lupus erythematosus (SLE) patients requires difficult trade-offs between efficacy and risk of toxicity. This qualitative study examined SLE patients' most desired outcomes and their concerns with corticosteroid use in SLE treatment. Methods SLE patients with current/past experience with using corticosteroids were recruited from the clinics at the Johns Hopkins Lupus Center and the University of Maryland Medical Center. Five in-depth interviews ( N = 5) and four focus groups ( N = 15) were conducted during which discussions were transcribed and analyzed based on a grounded theory approach. Results We identified five major themes describing SLE patients' most desired outcomes: reduction in flares, maintenance of normal activities, minimization of treatment side effects, prevention of future organ damage, and finding a cure. Further, SLE patients reported these primary concerns with the adverse effects of corticosteroids: weight gain, organ damage (particularly bone-related damage), mood swings/irritability, sleep disturbances, and dental issues. Patients appeared to be more concerned with adverse effects that immediately affected their day-to-day lives. Conclusion Knowledge gained during this study better informs how patients view the benefits and risks of corticosteroids. This can facilitate discussions between physicians and patients as they work together to determine the appropriate use of corticosteroids.

摘要

介绍 系统性红斑狼疮 (SLE) 患者使用皮质类固醇需要在疗效和毒性风险之间进行艰难的权衡。这项定性研究探讨了 SLE 患者最希望达到的治疗结果以及他们对 SLE 治疗中皮质类固醇使用的担忧。 方法 从约翰霍普金斯狼疮中心和马里兰大学医学中心的诊所招募了目前/过去有皮质类固醇使用经验的 SLE 患者。共进行了 5 次深入访谈( N = 5)和 4 次焦点小组( N = 15),根据扎根理论方法对讨论进行转录和分析。 结果 我们确定了五个主要主题,描述了 SLE 患者最希望达到的治疗结果:减少发作、维持正常活动、最小化治疗副作用、预防未来器官损伤和寻找治愈方法。此外,SLE 患者报告了这些对皮质类固醇不良反应的主要担忧:体重增加、器官损伤(特别是与骨骼相关的损伤)、情绪波动/易怒、睡眠障碍和牙齿问题。患者似乎更担心那些立即影响日常生活的不良反应。 结论 本研究获得的知识更好地说明了患者如何看待皮质类固醇的益处和风险。这可以促进医生和患者之间的讨论,因为他们共同努力确定皮质类固醇的适当使用。

相似文献

3
Patients' Preferences for Systemic Lupus Erythematosus Treatments-A Discrete Choice Experiment.
Patient. 2024 May;17(3):287-300. doi: 10.1007/s40271-023-00670-7. Epub 2024 Jan 25.
5
Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.
Lupus. 2014 Sep;23(10):1006-13. doi: 10.1177/0961203314532699. Epub 2014 Apr 30.
6
Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study.
J Rheumatol. 2024 May 1;51(5):488-494. doi: 10.3899/jrheum.2023-0721.
7
Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.
Clin Ther. 2016 Mar;38(3):610-24. doi: 10.1016/j.clinthera.2016.01.016. Epub 2016 Feb 19.
8
Corticosteroid-associated lupus pancreatitis: a case series and systematic review of the literature.
Lupus. 2019 May;28(6):731-739. doi: 10.1177/0961203319844004. Epub 2019 Apr 25.
9
Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus.
Arthritis Rheum. 1994 Sep;37(9):1311-20. doi: 10.1002/art.1780370907.

引用本文的文献

1
4
Patient Experiences of Systemic Lupus Erythematosus: Findings From a Systematic Review, Meta-Summary, and Meta-Synthesis.
Arthritis Care Res (Hoboken). 2022 Nov;74(11):1813-1821. doi: 10.1002/acr.24639. Epub 2022 Jul 13.
5
Self-reported disease severity in women with systemic lupus erythematosus.
Rheumatol Int. 2019 Mar;39(3):533-539. doi: 10.1007/s00296-018-4203-1. Epub 2018 Nov 10.

本文引用的文献

2
Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel.
Lupus. 2014 Sep;23(10):1006-13. doi: 10.1177/0961203314532699. Epub 2014 Apr 30.
4
The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey.
Rheumatology (Oxford). 2013 Dec;52(12):2292-301. doi: 10.1093/rheumatology/ket300. Epub 2013 Sep 18.
5
Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus.
Am J Epidemiol. 2012 Oct 15;176(8):708-19. doi: 10.1093/aje/kws130. Epub 2012 Sep 27.
9
Quality-of-life measurements versus disease activity in systemic lupus erythematosus.
Curr Rheumatol Rep. 2010 Aug;12(4):250-8. doi: 10.1007/s11926-010-0114-1.
10
PRO development: rigorous qualitative research as the crucial foundation.
Qual Life Res. 2010 Oct;19(8):1087-96. doi: 10.1007/s11136-010-9677-6. Epub 2010 May 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验